TW200630368A - Hydrate of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-α]-pyrimidin-7-yl}phenyl)acetamide and processes and methods related thereto - Google Patents

Hydrate of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-α]-pyrimidin-7-yl}phenyl)acetamide and processes and methods related thereto

Info

Publication number
TW200630368A
TW200630368A TW094136194A TW94136194A TW200630368A TW 200630368 A TW200630368 A TW 200630368A TW 094136194 A TW094136194 A TW 094136194A TW 94136194 A TW94136194 A TW 94136194A TW 200630368 A TW200630368 A TW 200630368A
Authority
TW
Taiwan
Prior art keywords
thienylcarbonyl
pyrazol
pyrimidin
acetamide
phenyl
Prior art date
Application number
TW094136194A
Other languages
English (en)
Inventor
Scott E Zook
Donald Hettinger
Original Assignee
Neurocrine Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurocrine Biosciences Inc filed Critical Neurocrine Biosciences Inc
Publication of TW200630368A publication Critical patent/TW200630368A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Anesthesiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
TW094136194A 2004-10-18 2005-10-17 Hydrate of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-α]-pyrimidin-7-yl}phenyl)acetamide and processes and methods related thereto TW200630368A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62001404P 2004-10-18 2004-10-18

Publications (1)

Publication Number Publication Date
TW200630368A true TW200630368A (en) 2006-09-01

Family

ID=35708797

Family Applications (1)

Application Number Title Priority Date Filing Date
TW094136194A TW200630368A (en) 2004-10-18 2005-10-17 Hydrate of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-α]-pyrimidin-7-yl}phenyl)acetamide and processes and methods related thereto

Country Status (6)

Country Link
US (2) US7304069B2 (zh)
EP (1) EP1844047A1 (zh)
JP (1) JP5156381B2 (zh)
AR (1) AR053979A1 (zh)
TW (1) TW200630368A (zh)
WO (1) WO2006044903A1 (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1918290A1 (en) 2006-10-11 2008-05-07 Ferrer Internacional, S.A. Polymorph B of N-{2-Fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo[1,5-a] pyrimidin-7-yl]-phenyl}-N-methyl-acetamide

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9820405D0 (en) * 1998-09-18 1998-11-11 Smithkline Beecham Plc Process
US6472528B1 (en) 1999-08-10 2002-10-29 Neurocrine Biosciences, Inc. Synthesis of substituted pyrazolopyrimidines
US6399621B1 (en) 1999-08-10 2002-06-04 American Cyanamid Company N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1, 5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
US6485746B1 (en) 2000-08-25 2002-11-26 Neurocrine Biosciences, Inc. Controlled-release sedative-hypnotic compositions and methods related thereto
US6384221B1 (en) * 1999-09-02 2002-05-07 Neurocrine Biosciences, Inc. Polymorphs of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
PL374436A1 (en) 2002-08-26 2005-10-17 Neurocrine Biosciences, Inc. Novel polymorph of n-methyl-n-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-alpha]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
AU2005215376B2 (en) * 2004-02-18 2011-01-20 Sunovion Pharmaceuticals Inc. Dopamine-agonist combination therapy with sedatives for improving sleep quality

Also Published As

Publication number Publication date
JP2008516987A (ja) 2008-05-22
US20080132700A1 (en) 2008-06-05
AR053979A1 (es) 2007-05-30
WO2006044903A1 (en) 2006-04-27
EP1844047A1 (en) 2007-10-17
JP5156381B2 (ja) 2013-03-06
US7304069B2 (en) 2007-12-04
US20060116387A1 (en) 2006-06-01

Similar Documents

Publication Publication Date Title
PL374436A1 (en) Novel polymorph of n-methyl-n-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-alpha]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
HK1081945A1 (en) Process for the synthesis of 4,5-dimethoxy-1-(methylaminomethyl)-benzocy clobutane, and the use thereof
MX2007005933A (es) Compuestos de acetamida como fungicidas.
PL1755606T5 (pl) Pochodne chinazolinonu użyteczne jako antagoniści receptora waniloidowego
GEP20104895B (en) Preparation of pregabalin and related compounds
WO2005087724A3 (en) Sulphonylpyrroles as hdac inhibitors
MXPA03008973A (es) Uso de bencilidenaminoguanidinas como ligandos para receptores de melanocortina.
RS20050648A (en) Dihydropteridinones,metod for the production and use thereof in the form of drugs
TNSN07272A1 (en) Substituted bis aryl and heteroaryl compounds as selective 5ht 2a antagonists
SG158848A1 (en) Method for producing annelated piperazin-2-one derivatives and intermediates of said method
ZA200705044B (en) Bi- and tricyclic substituted phenyl methanones as glycine transporter I (GLYT-1) inhibitors for the treatment of Alzheimer's disease
IL178156A0 (en) Intermediates for the preparation of pramipexole
WO2006035244A8 (en) Ecteinascidin compounds as anti -inflammatory agents
MX2007003427A (es) Sintesis eficiente de 4,5-dihidro-pirazolo[3,4-c]pirid-2-onas.
BR0013138A (pt) Sìntese de pirazolopirimidinas substituìdas
TW200630368A (en) Hydrate of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-α]-pyrimidin-7-yl}phenyl)acetamide and processes and methods related thereto
SI1888537T1 (sl) Postopek priprave 4-((1,6-dihidro-6-okso-2-pirimidinil)amino benzonitrila
GB2441840A (en) Process for the synthesis of arylfluorenes and analogues thereof
PL353362A1 (en) Polymorphs of n-methyl-n-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-alpha]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
MX2007007554A (es) Oxiarenos sustituidos.
WO2006062901A3 (en) Silacycle compounds and methods of use thereof
TW200626597A (en) Efficient synthesis of 4, 5-dihydro-pyrazolo [3, 4-c]pyrid-2-ones
ZA200201349B (en) Polymorphs of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-α]-pyrimidin-7-yl} phenyl)acetamide and compositions and methods related thereto.
TW200700423A (en) Heterobicyclic acrylamides
TW200626595A (en) Process for preparing 4, 5-dihydro-pyrazolo [3, 4-c]pyrid-2-ones